Skip to main content

Terns Pharmaceuticals, Inc.

TERNDelisted May 5, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001831363

Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.

13F holders, Q3 2024

Institutional positions in Terns Pharmaceuticals, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
156
+31 vs. Q2 2024
Shares held
79.5M
+18.0M (+29.4%) vs. Q2 2024
Total value
$663.1M
+$244.5M (+58.4%) vs. Q2 2024
New holders
54
52 more added
Sold out
23
37 more reduced

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TERN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 156 institutions
Q1 2021: 42 institutionsQ2 2021: 36 institutionsQ3 2021: 34 institutionsQ4 2021: 37 institutionsQ1 2022: 44 institutionsQ2 2022: 42 institutionsQ3 2022: 45 institutionsQ4 2022: 65 institutionsQ1 2023: 79 institutionsQ2 2023: 103 institutionsQ3 2023: 93 institutionsQ4 2023: 103 institutionsQ1 2024: 112 institutionsQ2 2024: 126 institutionsQ3 2024: 156 institutionsQ4 2024: 157 institutionsQ1 2025: 138 institutionsQ2 2025: 130 institutionsQ3 2025: 141 institutionsQ4 2025: 248 institutionsQ1 2026: 317 institutionsQ2 2026: 1 institution
Value heldQ3 2024: $663.1M
Q1 2021: $393.7MQ2 2021: $203.8MQ3 2021: $174.3MQ4 2021: $116.7MQ1 2022: $50.0MQ2 2022: $36.5MQ3 2022: $178.1MQ4 2022: $506.2MQ1 2023: $630.2MQ2 2023: $505.0MQ3 2023: $310.4MQ4 2023: $412.7MQ1 2024: $414.8MQ2 2024: $446.7MQ3 2024: $663.1MQ4 2024: $477.2MQ1 2025: $229.4MQ2 2025: $310.0MQ3 2025: $665.7MQ4 2025: $4.95BQ1 2026: $6.56BQ2 2026: $75.4K
Institutions holding TERN and their total value by quarter
QuarterHoldersValue
Q2 20261$75.4K
Q1 2026317$6.56B
Q4 2025248$4.95B
Q3 2025141$665.7M
Q2 2025130$310.0M
Q1 2025138$229.4M
Q4 2024157$477.2M
Q3 2024156$663.1M
Q2 2024126$446.7M
Q1 2024112$414.8M
Q4 2023103$412.7M
Q3 202393$310.4M
Q2 2023103$505.0M
Q1 202379$630.2M
Q4 202265$506.2M
Q3 202245$178.1M
Q2 202242$36.5M
Q1 202244$50.0M
Q4 202137$116.7M
Q3 202134$174.3M
Q2 202136$203.8M
Q1 202142$393.7M

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Terns Pharmaceuticals, Inc.; share changes are against Q2 2024.

Institutions holding TERN in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
NEOS Investment Management LLC128,305$1.07M0.03%−36,916−22.3%Reduced
HighVista Strategies LLC130,966$1.09M0.38%−17,234−11.6%Reduced
Bridger Management, LLC142,300$1.19M0.59%−104,500−42.3%Reduced
Two Sigma Investments, LP144,256$1.20M0.00%+82,833+134.9%Added
Alyeska Investment Group, L.P.150,000$1.25M0.01%+150,000New
Charles Schwab Investment Management Inc154,714$1.29M0.00%+1,994+1.3%Added
Voloridge Investment Management, LLC157,786$1.32M0.00%+157,786New
Bank of New York Mellon Corp161,378$1.35M0.00%−15,295−8.7%Reduced
Cinctive Capital Management LP168,564$1.41M0.08%+168,564New
Walleye Capital LLC185,795$1.55M0.02%+185,795New
Cubist Systematic Strategies, LLC186,578$1.56M0.02%+186,578New
Samsara BioCapital, LLC202,348$1.69M0.32%00.0%Unchanged
J. Goldman & Co LP203,941$1.70M0.07%+203,941New
Wellington Management Group LLP222,065$1.85M0.00%−2,111−0.9%Reduced
Alliancebernstein L.P.244,576$2.04M0.00%−53,488−17.9%Reduced
Telemark Asset Management, LLC300,000$2.50M0.25%+300,000New
Integral Health Asset Management, LLC300,000$2.50M0.29%+300,000New
Woodline Partners LP301,224$2.51M0.02%−443,820−59.6%Reduced
Trexquant Investment LP303,916$2.53M0.03%+270,193+801.2%Added
Ikarian Capital, LLC308,497$2.57M0.80%−150,000−32.7%Reduced
Altium Capital Management LP330,000$2.75M0.82%+330,000New
Salem Investment Counselors Inc376,600$3.14M0.09%+5,000+1.3%Added
Goldman Sachs Group Inc418,867$3.49M0.00%−279,847−40.1%Reduced
StemPoint Capital LP449,321$3.75M1.12%+449,321New
Qube Research & Technologies Ltd456,939$3.81M0.01%+456,939New
Northern Trust Corp463,875$3.87M0.00%+116,108+33.4%Added
Renaissance Technologies LLC479,500$4.00M0.01%+392,000+448.0%Added
Acuta Capital Partners, LLC487,000$4.06M3.29%+117,720+31.9%Added
Deutsche Bank AG542,846$4.53M0.00%+445,668+458.6%Added
Parkman Healthcare Partners LLC545,751$4.55M0.58%+155,481+39.8%Added
Affinity Asset Advisors, LLC600,000$5.00M0.78%+600,000New
Dimensional Fund Advisors LP629,362$5.25M0.00%+257,470+69.2%Added
Russell Investments Group, Ltd.744,687$6.21M0.01%+96,571+14.9%Added
Boxer Capital, LLC752,000$6.27M0.31%+752,000New
Morgan Stanley782,932$6.53M0.00%+449,314+134.7%Added
Bellevue Group AG1,042,135$8.69M0.14%+1,042,135New
State Street Corp1,116,991$9.32M0.00%−59,842−5.1%Reduced
FMR LLC1,172,524$9.78M0.00%−1,594,572−57.6%Reduced
Geode Capital Management, LLC1,207,479$10.1M0.00%+85,617+7.6%Added
Superstring Capital Management LP1,348,546$11.2M10.06%+392,004+41.0%Added
Price T Rowe Associates Inc1,475,679$12.3M0.00%+1,448,996+5,430.4%Added
Millennium Management LLC1,578,534$13.2M0.01%+438,142+38.4%Added
ExodusPoint Capital Management, LP1,648,131$13.7M0.14%+1,648,131New
Nuveen Asset Management, LLC2,016,909$16.8M0.00%+1,269,467+169.8%Added
Driehaus Capital Management LLC2,091,801$17.4M0.15%+1,007,896+93.0%Added
Avidity Partners Management LP2,133,872$17.8M0.91%+2,133,872New
Point72 Asset Management, L.P.2,707,515$22.6M0.08%+17,139+0.6%Added
Schonfeld Strategic Advisors LLC3,289,826$27.4M0.22%+1,021,398+45.0%Added
Vanguard Group Inc3,356,814$28.0M0.00%+1,055,872+45.9%Added
VR Adviser, LLC3,410,058$28.4M1.49%00.0%Unchanged
Citadel Advisors LLC3,673,226$30.6M0.03%+2,213,276+151.6%Added
BlackRock, Inc.4,698,771$39.2M0.00%+4,698,771New
Deep Track Capital, LP5,576,558$46.5M1.48%−523,442−8.6%Reduced
Soleus Capital Management, L.P.6,223,544$51.9M4.32%+1,275,806+25.8%Added
Vivo Capital, LLC6,895,746$57.5M4.76%+712,754+11.5%Added
OrbiMed Advisors LLC7,562,971$63.1M1.15%−56,164−0.7%Reduced
Octagon Capital Advisors LP0$00.00%−1,364,400−100.0%Sold out
Great Point Partners LLC0$00.00%−1,149,406−100.0%Sold out
Franklin Resources Inc0$00.00%−1,122,842−100.0%Sold out
Adage Capital Partners GP, L.L.C.0$00.00%−975,000−100.0%Sold out
Fairmount Funds Management LLC0$00.00%−748,996−100.0%Sold out
Eversept Partners, LP0$00.00%−286,266−100.0%Sold out
DAFNA Capital Management LLC0$00.00%−86,000−100.0%Sold out
Bank of Montreal0$00.00%−40,971−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−19,161−100.0%Sold out
Worth Venture Partners, LLC0$00.00%−17,470−100.0%Sold out
Fox Run Management, L.L.C.0$00.00%−16,503−100.0%Sold out
Alpine Global Management, LLC0$00.00%−16,078−100.0%Sold out
Walleye Trading LLC0$00.00%−15,000−100.0%Sold out
Oxford Asset Management LLP0$00.00%−14,689−100.0%Sold out
Zimmer Partners, LP0$00.00%−14,042−100.0%Sold out
Simplicity Wealth,LLC0$00.00%−10,561−100.0%Sold out
EntryPoint Capital, LLC0$00.00%−9,069−100.0%Sold out
Advisor Group Holdings, Inc.0$00.00%−2,299−100.0%Sold out
Stone House Investment Management, LLC0$00.00%−1,000−100.0%Sold out
Meeder Asset Management Inc0$00.00%−772−100.0%Sold out
US Bancorp0$00.00%−600−100.0%Sold out
Allworth Financial LP0$00.00%−90−100.0%Sold out
National Bank of Canada0$00.00%−100−100.0%Sold out
BlackRock Inc.––––Not filed